METASTATIC BLADDER UROTHELIAL CARCINOMA
Clinical trials for METASTATIC BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a targeted drug shrink tumors in patients with specific gene mutations?
Disease control Recruiting nowThis study tests the drug pemetrexed in people with metastatic bladder cancer or other solid tumors that have certain gene mutations (MLL4, UTX, or MTAP). The goal is to see if the drug can shrink tumors. About 64 adults will take pemetrexed and be monitored for response every 9 …
Matched conditions: METASTATIC BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 17, 2026 03:15 UTC
-
Can blood filtering revive bladder cancer treatment?
Disease control Recruiting nowThis study tests whether a blood-filtering procedure called plasma exchange can help standard drugs work better in people with advanced bladder cancer that has stopped responding to treatment. About 70 adults will receive either plasma exchange plus the drugs enfortumab vedotin a…
Matched conditions: METASTATIC BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 03:15 UTC
-
New combo therapy and surgery shows promise for advanced bladder cancer
Disease control Recruiting nowThis study tests a standard treatment of two drugs (enfortumab vedotin and pembrolizumab) followed by surgery to remove part or all of the bladder or urinary tract in people with advanced bladder cancer that has spread. The goal is to see if this approach helps patients live long…
Matched conditions: METASTATIC BLADDER UROTHELIAL CARCINOMA
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Tumor tissue study aims to predict cancer treatment success
Knowledge-focused Recruiting nowThis study collects tissue samples from people with various advanced or early-stage cancers to train a new diagnostic platform called Elephas. The goal is to see how accurately it can predict whether a patient will respond to immunotherapy or chemoimmunotherapy. About 324 partici…
Matched conditions: METASTATIC BLADDER UROTHELIAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC